Biggest News Aggregation in the World
📰 Repligen Daily News

Page 2 - Repligen Daily News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Repligen Daily. Real-time updates on events, politics, business and more.

Dana Investment Advisors Inc. Decreases Stock Position in Repligen Co. (NASDAQ:RGEN)

Dana Investment Advisors Inc. lowered its stake in Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during the period. Dana Investment Advisors […]
United States Karena Dawes Asia Pacific Stifel Nicolaus James Bylund Invesco Ltd

Repligen Co. (NASDAQ:RGEN) Shares Sold by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. lessened its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 36.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,437 shares of the biotechnology company’s stock after selling 2,546 shares during […]
United States Karena Dawes Asia Pacific Stifel Nicolaus James Bylund Park Place Capital Corp

WealthPlan Investment Management LLC Purchases Shares of 1,320 Repligen Co. (NASDAQ:RGEN)

WealthPlan Investment Management LLC purchased a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,320 shares of the biotechnology company’s stock, valued at approximately $210,000. A number of other hedge […]
United States Stifel Nicolaus Karena Dawes Asia Pacific James Bylund Wealthplan Investment Management
Source: wkrb13.com

Repligen Co. (NASDAQ:RGEN) to Post Q1 2024 Earnings of $0.30 Per Share, William Blair Forecasts

Repligen Co. (NASDAQ:RGEN – Free Report) – Stock analysts at William Blair cut their Q1 2024 earnings per share (EPS) estimates for shares of Repligen in a research report issued to clients and investors on Thursday, February 22nd. William Blair analyst M. Larew now forecasts that the biotechnology company will earn $0.30 per share for […]
United States James Bylund William Blair Asia Pacific Repligen Co V Square Quantitative Management

Primecap Management Co. CA Increases Position in Repligen Co. (NASDAQ:RGEN)

Primecap Management Co. CA boosted its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 6.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,629 shares of the biotechnology company’s stock after purchasing an additional 3,250 shares […]
United States Asia Pacific Stifel Nicolaus James Bylund Repligen Company Profile Repligen Corporation

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Repligen (NASDAQ:RGEN) Shares Gap Down to $199.73

Repligen Co. (NASDAQ:RGEN – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $199.73, but opened at $187.80. Repligen shares last traded at $198.30, with a volume of 185,706 shares changing hands. Wall Street Analysts Forecast Growth A number of brokerages recently weighed in on RGEN. KeyCorp […]
United States Asia Pacific Royal Bank Repligen Co Repligen Corporation Repligen Company Profile

DekaBank Deutsche Girozentrale Boosts Holdings in Repligen Co. (NASDAQ:RGEN)

DekaBank Deutsche Girozentrale grew its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 1.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,457 shares of the biotechnology company’s stock after buying an additional 159 shares […]
United States Dekabank Deutsche Girozentrale Stifel Nicolaus Asia Pacific First Horizon Advisors Inc Repligen Co

Repligen (NASDAQ:RGEN) Posts Quarterly Earnings Results, Meets Estimates

Repligen (NASDAQ:RGEN – Get Free Report) released its earnings results on Wednesday. The biotechnology company reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33, Briefing.com reports. The business had revenue of $155.74 million for the quarter, compared to analyst estimates of $155.38 million. Repligen had a return on equity […]
United Kingdom United States Asia Pacific Stifel Nicolaus Cambridge Investment Research Advisors Inc Lazard Asset Management

Repligen (NASDAQ:RGEN) Announces Earnings Results

Repligen (NASDAQ:RGEN – Get Free Report) issued its earnings results on Wednesday. The biotechnology company reported $0.33 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.33, Briefing.com reports. The company had revenue of $155.74 million during the quarter, compared to analysts’ expectations of $155.38 million. Repligen had a return on equity […]
United States Stifel Nicolaus Asia Pacific Belpointe Asset Management Repligen Corporation United Capital Financial Advisers

Repligen (NASDAQ:RGEN) Releases FY24 Earnings Guidance

Repligen (NASDAQ:RGEN – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $1.42-1.49 for the period, compared to the consensus estimate of $1.77. The company issued revenue guidance of $620-650 million, compared to the consensus revenue estimate of $660.67 million. Repligen also […]
United States Asia Pacific Stifel Nicolaus Milestone Investment Advisors Covestor Ltd Royal Bank
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science